Market Overview

The Global Polycystic Ovarian Syndrome Market was valued at USD 6,844.0 million in 2023 and is expected to reach USD 10,189.0 million by 2031 while growing at a CAGR of 5.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global polycystic ovarian syndrome market growth. The Polycystic Ovarian Syndrome (PCOS) market encompasses pharmaceuticals, healthcare products, and services targeting the diagnosis, treatment, and management of this prevalent hormonal disorder in reproductive-age women. It includes a spectrum of interventions, such as medications, medical devices, diagnostics, and lifestyle management programs.

The rising prevalence of PCOS, alongside continuous research and development efforts contributing to advancements in diagnostic techniques, treatment modalities, and management strategies, propels the polycystic ovarian syndrome (PCOS) market. Nevertheless, obstacles such as high treatment costs and issues with underdiagnosis and misdiagnosis impede the market's growth.

Furthermore, the global polycystic ovarian syndrome industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Polycystic Ovarian Syndrome Market is segmented among Oral Contraceptives, Antiandrogens, Insulin-Sensitizing Agent, Antidepressant, and Anti-obesity, based on Drug Class. In 2023, Antiandrogens accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Surgery Analysis

The Global Polycystic Ovarian Syndrome Market is segmented among Ovarian Wedge Resection, and Laparoscopic Ovarian Drilling, based on Surgery. In 2023, Laparoscopic Ovarian Drilling accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Polycystic Ovarian Syndrome Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are AstraZeneca, Bayer AG, Merck KGaA, Abbott, Pfizer, Inc., Sanofi, Bristol Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Novartis AG, and Ferring B.V.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Polycystic Ovarian Syndrome Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Polycystic Ovarian Syndrome Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Polycystic Ovarian Syndrome Market Segmentation, By Drug Class

• Global Polycystic Ovarian Syndrome Market Share Analysis, By Drug Class

• Global Polycystic Ovarian Syndrome Market Growth Analysis, By Drug Class

• Global Polycystic Ovarian Syndrome Market Trends, By Drug Class

o Oral Contraceptives

o Antiandrogens

o Insulin-Sensitizing Agent

o Antidepressant

o Anti-obesity

6. Global Polycystic Ovarian Syndrome Market Segmentation, By Surgery

• Global Polycystic Ovarian Syndrome Market Share Analysis, By Surgery

• Global Polycystic Ovarian Syndrome Market Growth Analysis, By Surgery

• Global Polycystic Ovarian Syndrome Market Trends, By Surgery

o Ovarian Wedge Resection

o Laparoscopic Ovarian Drilling

7. Global Polycystic Ovarian Syndrome Market Segmentation, By Region

• Global Polycystic Ovarian Syndrome Market Share Analysis, By Region

• Global Polycystic Ovarian Syndrome Market Growth Analysis, By Region

• Global Polycystic Ovarian Syndrome Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• AstraZeneca*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Bayer AG

• Merck KGaA

• Abbott

• Pfizer, Inc.

• Sanofi

• Bristol Myers Squibb Company

• Teva Pharmaceutical Industries Ltd.

• Novartis AG

• Ferring B.V.

*Similar analysis will be provided for each company listed above.